BOT 3.49% 8.3¢ botanix pharmaceuticals ltd

repeating this notion that ".....they’re covered for the next...

  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    repeating this notion that ".....they’re covered for the next two years and that’s a big thing” needs to be substantiated though, either their last quarterly is wrong and Bernberg is right or vice-versa.
    What has been released to the market is that cash burn is currently forecasted @5.94m/Q:
    Even allowing for a generous R&D rebate of $7m brings the total (retrograde) cash at the end of June to 31.6m, that correspondS to 5.32 quarters: running out of cash around November next year until they announce otherwise.
    BOT has great potential but a CR will come for its phase 3 acne trial, until they deliver some "non-dilutive funding arrangement", let's keep it real.
    Last edited by aburbe: 06/08/20
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $80.77M
Open High Low Value Volume
8.5¢ 8.5¢ 8.2¢ $150.2K 1.798M

Buyers (Bids)

No. Vol. Price($)
2 242881 8.3¢

Sellers (Offers)

Price($) Vol. No.
8.4¢ 329156 1
View Market Depth
Last trade - 15.09pm 06/05/2021 (20 minute delay) ?
-0.003 ( 1.22 %)
Open High Low Volume
8.5¢ 8.5¢ 8.2¢ 613266
Last updated 15.35pm 06/05/2021 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.